https://www.creative-biolabs.com/gene-therapy/alzheimer-disease.htm
In the past decades, the adeno-associated virus (AAV) has been developed as a promising nonpathogenic vector of gene therapy to treat neurodegenerative diseases in the central nervous system (CNS). With expertise in AAV and years of experience, Creative Biolabs offers a wide range of AAV vector design service to suit your basic research and gene therapy needs.
                                    
                                




